Recital 261, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

It is therefore concluded that there are no mitigating circumstances applicable to the participants in the present infringement affecting the methylglucamine market.

3.3.7. Application of the Leniency Notice